356 related articles for article (PubMed ID: 26437369)
21. JC polyomavirus DNA detection in clinical practice.
Kartau M; Auvinen E; Verkkoniemi-Ahola A; Mannonen L; Helanterä I; Anttila VJ
J Clin Virol; 2022 Jan; 146():105051. PubMed ID: 34883406
[TBL] [Abstract][Full Text] [Related]
22. Comparison of qPCR with ddPCR for the Quantification of JC Polyomavirus in CSF from Patients with Progressive Multifocal Leukoencephalopathy.
Ngouth N; Monaco MC; Walker L; Corey S; Ikpeama I; Fahle G; Cortese I; Das S; Jacobson S
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746716
[TBL] [Abstract][Full Text] [Related]
23. Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus.
Shimbo E; Nukuzuma S; Tagawa YI
Biochem Biophys Res Commun; 2020 Dec; 533(4):983-987. PubMed ID: 33008586
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of JC polyomavirus infectivity by the retrograde transport inhibitor Retro-2.1.
Treasure T; Nelson CDS
Microbiol Immunol; 2020 Dec; 64(12):783-791. PubMed ID: 32965709
[TBL] [Abstract][Full Text] [Related]
25. Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy.
Jelcic I; Combaluzier B; Jelcic I; Faigle W; Senn L; Reinhart BJ; Ströh L; Nitsch RM; Stehle T; Sospedra M; Grimm J; Martin R
Sci Transl Med; 2015 Sep; 7(306):306ra150. PubMed ID: 26400911
[TBL] [Abstract][Full Text] [Related]
26. The human JC polyomavirus (JCPyV): virological background and clinical implications.
Hirsch HH; Kardas P; Kranz D; Leboeuf C
APMIS; 2013 Aug; 121(8):685-727. PubMed ID: 23781977
[TBL] [Abstract][Full Text] [Related]
27. Utility of droplet digital PCR for the quantitative detection of polyomavirus JC in clinical samples.
Giovannelli I; Ciccone N; Vaggelli G; Malva ND; Torricelli F; Rossolini GM; Giannecchini S
J Clin Virol; 2016 Sep; 82():70-75. PubMed ID: 27454232
[TBL] [Abstract][Full Text] [Related]
28. Progressive Multifocal Leukoencephalopathy Following Combined Rituximab-Based Immune-Chemotherapy for Post-transplant Lymphoproliferative Disorder in a Renal Transplant Recipient: A Case Report.
Windpessl M; Burgstaller S; Kronbichler A; Pieringer H; Kalev O; Karrer A; Wallner M; Thaler J
Transplant Proc; 2018 Apr; 50(3):881-883. PubMed ID: 29661457
[TBL] [Abstract][Full Text] [Related]
29. Progressive Multifocal Leukoencephalopathy: Endemic Viruses and Lethal Brain Disease.
Haley SA; Atwood WJ
Annu Rev Virol; 2017 Sep; 4(1):349-367. PubMed ID: 28637388
[TBL] [Abstract][Full Text] [Related]
30. Polyomavirus BK and JC in individuals with chronic kidney failure, kidney transplantation, and healthy controls.
Castro T; Fink MCD; Figueiredo M; Braz-Silva PH; Pannuti CM; Ortega KL; Gallottini M
J Clin Virol; 2017 Apr; 89():5-9. PubMed ID: 28189092
[TBL] [Abstract][Full Text] [Related]
31. Polyoma nephropathy and progressive multifocal leukoencephalopathy in a renal transplant recipient.
Phillips T; Jacobs R; Ellis EN
J Child Neurol; 2004 Apr; 19(4):301-4. PubMed ID: 15163098
[TBL] [Abstract][Full Text] [Related]
32. ERK Is a Critical Regulator of JC Polyomavirus Infection.
DuShane JK; Wilczek MP; Mayberry CL; Maginnis MS
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321332
[TBL] [Abstract][Full Text] [Related]
33. Archetype JC polyomavirus DNA associated with extracellular vesicles circulates in human plasma samples.
Scribano S; Guerrini M; Arvia R; Guasti D; Nardini P; Romagnoli P; Giannecchini S
J Clin Virol; 2020 Jul; 128():104435. PubMed ID: 32442760
[TBL] [Abstract][Full Text] [Related]
34. Prospective study of posttransplant polyomavirus infection in renal transplant recipients.
Hu J; Zhao H; Huang Y; Zhang X; Gao H; Yang M; Fan J; Ma W
Exp Clin Transplant; 2011 Jun; 9(3):175-80. PubMed ID: 21649565
[TBL] [Abstract][Full Text] [Related]
35. The JCPYV DNA load inversely correlates with the viral microrna expression in blood and cerebrospinal fluid of patients at risk of PML.
Rocca A; Martelli F; Delbue S; Ferrante P; Bartolozzi D; Azzi A; Giannecchini S
J Clin Virol; 2015 Sep; 70():1-6. PubMed ID: 26305810
[TBL] [Abstract][Full Text] [Related]
36. Distribution of JC polyomavirus genotypes in Tunisian renal transplant recipients between January 2008 and January 2011.
Boukoum H; Nahdi I; Abid N; Foulongne V; Sahtout W; Zallema D; Skiri H; Aloui S; Achour A; Segondy M; Aouni M
J Med Virol; 2012 Nov; 84(11):1818-24. PubMed ID: 22997086
[TBL] [Abstract][Full Text] [Related]
37. Studies of human polyomaviruses, with HPyV7, BKPyV, and JCPyV present in urine of allogeneic hematopoietic stem cell transplanted patients with or without hemorrhagic cystitis.
Franzén J; Ramqvist T; Bogdanovic G; Grün N; Mattson J; Dalianis T
Transpl Infect Dis; 2016 Apr; 18(2):240-6. PubMed ID: 26809742
[TBL] [Abstract][Full Text] [Related]
38. Management of infections by the human polyomavirus JC: past, present and future.
Hou J; Major E
Expert Rev Anti Infect Ther; 2005 Aug; 3(4):629-40. PubMed ID: 16107201
[TBL] [Abstract][Full Text] [Related]
39. Establishment of COS-JC cells persistently producing archetype JC polyomavirus.
Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
Microbiol Immunol; 2018 Aug; 62(8):524-530. PubMed ID: 29932215
[TBL] [Abstract][Full Text] [Related]
40. Undetectable JC virus CSF PCR in patients with JC virus-induced progressive multifocal leukoencephalopathy.
Chiu CY; Amenta E; Chavez V; Fukuta Y; Hasbun R
J Neurovirol; 2023 Feb; 29(1):94-99. PubMed ID: 36723823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
